Secondary Pneumocystis jirovecii pneumonia in one non-HIV patient during recovery period of COVID-19

doi:10.3760/cma.j.issn.1007-1245.2023.20.024

International Medicine and Health Guidance News ›› 2023, Vol. 29 ›› Issue (20): 2937-2940.DOI: 10.3760/cma.j.issn.1007-1245.2023.20.024

• Case Report • Previous Articles Next Articles

Secondary Pneumocystis jirovecii pneumonia in one non-HIV patient during recovery period of COVID-19

Li Fei, Guo Lijuan, Wu Jingbo, Shi Xinjie

Department of Respiratory and Critical Care Medicine, Weihai Central Hospital, Qingdao University, Weihai 264400, China

Received:2023-04-28 Online:2023-10-15 Published:2023-11-06
Contact: Shi Xinjie, Email: cong19751999@sina.com

非HIV患者新型冠状病毒感染恢复期继发耶氏肺孢子菌肺炎1例

李飞郭丽娟吴京波时新杰

青岛大学附属威海市中心医院呼吸与危重症医学科，威海　264400

通讯作者: 时新杰，Email：cong19751999@sina.com

Abstract

Abstract:

Pneumocystis jirovecii (PJ) is an opportunistic pathogen that can cause PJ pneumonia (PJP), which is common in human immunodeficiency virus (HIV) infected individuals. This paper reports a patient with COVID-19 and without underlying disease of HIV admitted to Department of Respiratory and Critical Care Medicine, Weihai Central Hospital, Qingdao University. The patient was improved after treatment but deteriorated during follow-up and was clearly diagnosed with PJP by the next-generation sequencing (NGS). This paper reviews the relevant literatures so as to provide some help for diagnosis and treatment of PJP.

Key words:

COVID-19, Pneumocystis jirovecii pneumonia, SARS-CoV-2, Pneumocystis jirovecii

摘要：

耶氏肺孢子菌（PJ）作为机会性致病菌，可引起PJ肺炎（PJP），人类免疫缺陷病毒（HIV）感染者多见。本文报道1例青岛大学附属威海市中心医院呼吸与危重症医学科收治的非HIV新型冠状病毒感染患者，经治疗病情好转，随访中再次出现临床症状加重、影像学病变进展，经二代测序技术（NGS）明确为PJP。复习相关文献，以期为临床诊治工作提供帮助。

关键词:

新型冠状病毒感染, 肺孢子菌肺炎, 新型冠状病毒, 耶氏肺孢子菌

Li Fei, Guo Lijuan, Wu Jingbo, Shi Xinjie.

Secondary Pneumocystis jirovecii pneumonia in one non-HIV patient during recovery period of COVID-19 [J]. International Medicine and Health Guidance News, 2023, 29(20): 2937-2940.

李飞郭丽娟吴京波时新杰.

非HIV患者新型冠状病毒感染恢复期继发耶氏肺孢子菌肺炎1例 [J]. 国际医药卫生导报, 2023, 29(20): 2937-2940.

References

[1] Hue S, Beldi-Ferchiou A, Bendib I, et al. Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2020, 202(11): 1509-1519. DOI: 10.1164/rccm.202005-1885OC.
[2] Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases [J]. Chest, 2020, 158(6): 2323-2332. DOI: 10.1016/j.chest.2020.05.558.
[3] Wang Y, Pang SC, Yang Y. A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases [J]. Immun Ageing, 2021, 18(1): 25. DOI: 10.1186/s12979-021-00234-z.
[4] Bienvenu AL, Traore K, Plekhanova I, et al. Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients [J]. Int J Infect Dis, 2016, 46: 11-17. DOI: 10.1016/j.ijid.2016.03.018.
[5] Nasr M, Mohammad A, Hor M, et al. Exploring the differences in pneumocystis pneumonia infection between HIV and non-HIV patients [J]. Cureus, 2022, 14(8): e27727. DOI:10.7759/cureus.27727.
[6] 代艳, 李新叶, 唐慧荷, 等. 非HIV感染的免疫低下者肺孢子菌肺炎防治进展[J]. 中国临床新医学, 2021, 14(2): 134-138. DOI: 10.3969/j.issn.1674-3806.2021.02.04.
[7] Asai N, Motojima S, Ohkuni Y, et al. Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection [J]. J Infect Chemother, 2012, 18(6): 898-905. DOI: 10.1007/s10156-012-0441-4.
[8] Chong WH, Saha BK, Austin A, et al. The significance of subpleural sparing in CT chest: a state-of-the-art review [J]. Am J Med Sci, 2021, 361(4): 427-435. DOI: 10.1016/j.amjms.2021.01.008.
[9] 张为,佘丹阳,谢晓玮,等. 二代测序技术在非人类免疫缺陷病毒感染者肺孢子菌肺炎诊断中的应用价值[J]. 中华结核和呼吸杂志,2020,43(10):844-849. DOI: 10.3760/cma.j.cn112147-20200416-00510.
[10] Tasaka S. Recent advances in the diagnosis and management of pneumocystis pneumonia [J]. Tuberc Respir Dis (Seoul), 2020, 83(2): 132-140. DOI:10.4046/trd.2020.0015.
[11] Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment [J]. Expert Opin Pharmacother, 2021, 22(12): 1579-1592. DOI:10.1080/14656566.2021.1915989.
[12] 段艳,徐媛,雷雯朴,等. 非HIV人群感染耶氏肺孢子菌肺炎的诊治研究进展[J]. 中国真菌学杂志,2022,17(5):435-440. DOI:10.3969/j.issn.1673-3827.2022.05.020.
[13] Catherinot E, Lanternier F, Bougnoux ME, et al. Pneumocystis jirovecii pneumonia [J]. Infect Dis Clin North Am, 2010, 24(1): 107-138. DOI: 10.1016/j.idc.2009.10.010.
[14] Povoa P, Coelho L, Salluh J. When should we use corticosteroids in severe community-acquired pneumonia? [J]. Curr Opin Infect Dis, 2021, 34(2): 169-174. DOI:10.1097/QCO.0000000000000709.
[15] Wang M, Zhang Z, Dong X, et al. Targeting beta-glucans, vital components of the pneumocystis cell wall [J]. Front Immunol, 2023, 14: 1094464. DOI: 10.3389/fimmu.2023.1094464.

Secondary Pneumocystis jirovecii pneumonia in one non-HIV patient during recovery period of COVID-19

非HIV患者新型冠状病毒感染恢复期继发耶氏肺孢子菌肺炎1例

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics

[1]	Zhu Yanyan, Zhuang Ruixia, Sun Qi, Feng Yuanyuan, Liang Shuang, Zhou Bo. Mental health status of medical graduate students at a university in closure because of COVID-19 epidemic [J]. International Medicine and Health Guidance News, 2023, 29(4): 497-501.
[2]	Jiang Junfei, Gao Yue, Yang Lin. Analysis of drugs for COVID-19 Omicron variant strain infection in Shanghai Songjiang Shelter Hospital [J]. International Medicine and Health Guidance News, 2023, 29(2): 170-.
[3]	Wang Jie, Liu Fangfang, Ma Kai, Liu Guiling, Liu Yong, Jin Ruifeng. Neurological manifestations of children infected with COVID-19 [J]. International Medicine and Health Guidance News, 2023, 29(16): 2245-2250.
[4]	Yue Xianghai, Yang Jing, Ren Chengli, Jiang Dongxiao, Bi Yuhua, Zhan Xia. One patient with reversible splenial lesion syndrome after novel coronavirus infection and literature review [J]. International Medicine and Health Guidance News, 2023, 29(14): 2016-2017.